SBJ-2 Osteoarthritis and Rheumatoid Arthritis
About this set
Created by:
ccaffrey Plus on February 27, 2012
Description:
Dr. Coulson
Log in to favorite or report as inappropriate.
Order by
97 terms
Terms | Definitions |
|---|---|
Osteoarthritis7 million Americans | What accounts for more disability among seniors than any other disease? |
No systemic, inflammation is mild, if at all present. | Systemic symptoms of osteoarthritis? |
Progressive degeneration of hands, spine, weight-bearing jointsHands: DIPs, PIPs, 1st CMC AC shoulder, C/T/L Spine Hips, cysts in superior acetabulum Knees 1MTP | What joints are typically affected by osteoarthritis? |
Osteoarthritis | What is the most common articular disorder? |
ObesityHeredity Age Previous joint trauma Smoking Certain occupations (with usage of the joint) | Risk factors for osteoarthritis? |
Present, but usually <30 minutes | Morning stiffness characteristics with OA? |
Associated with OA, it involves any period of prolonged rest that results in joint stiffness | What is the "gel phenomenon"? |
AM stiffness <30 minutesJoint pain / tenderness worse with activity, better with rest Crepitus (crunchy feeling) Bony swelling (Heberden's and Bouchard's nodes) Functional impairment (like decreased fine motor movement) Periarticular muscular atrophy | Clinical signs of OA? |
Non inflammatory synovial fluidHigh viscosity Clear and yellow WBC < 1-2 k | Lab findings in OA? |
Osteophytes (bone spurs)Non uniform joint space narrowing Subchondral cysts (e.g. in the superior acetabulum of the hips) Malalignment | XR findings in OA? |
Cartilage degeneration at point of maximal stress, with a non-uniform, focal joint space narrowing. | Primary problem in OA? |
Swelling of articular cartilage, and then breaking down articular cartilage which then thins and softens.Cartilage loss leads to subchondral bone sclerosis, trabecular compression, reactive bone deposition. Synovial fluid leaks into underlying bones, forming cysts Endochondral ossification | After cartilage degeneration, what can happen with OA? |
Both are slides of articular cartilage.Top is cross-section through normal hip cartilage, with abundant mucopolysaccharide Bottom shows degenerative changes in the articular cartilage indicative of OA. Hypercellularity, low MPS (pink) | ![]() |
DIP joint slide, showing irregular bony hypertrophy. The joint is trying to repair itself in the setting of OA, with no active inflammation | ![]() |
Heberden's nodes, seen in OA.If you push on these bony budges, these might be tender. They usually become non-tender in time. This is basically bony proliferation, in which proliferation of the bone kind of attempts to keep the joint from moving. | ![]() |
Synovial cyst seen in the setting of OA-derived Heberden's nodes. Not inflammatory. | ![]() |
Bouchard's nodes (bony proliferations surrounding the PIPs).Also seen here are Heberden's nodes | ![]() What is the cursor pointing to? |
Bone spurs (osteophytes) of the DIPs (Heberden's nodes), with irregular joint space narrowing. PIPs also have ireregular joint space narrowing.Also seen here are subluxation of the 1st MCP All in the setting of OA | ![]() What is abnormal |
OsteophytesBone sclerosis Bony compression Irregular joint space narrowing All in the setting of OA | ![]() |
Seen in the setting of erosive OAGull wing deformity, with osteophytes. Periarticular osteopenia is not present (thinning of bones around a particular joint) | ![]() |
Hip changes seen in the setting of OABone sclerosis of the right and especially the left hip. Left hip almost has obliteration of the joint space. | ![]() |
OA hips, advanced, very much so on the left. Complete obliteration of joint capsule, with bony growth and sclerosis. | ![]() |
Oral NSAIDs, ASA, AcetaminophenGlucosamine condroitin (nutritional supplement) Limbrel (Flavocoxid) - OTC Viscosupplementation (hyaluronic acid injections, qWeek for up to five weeks) Topical capsaicin Diclofenac patches Lidocaine patches Narcotics (esp low dose, Tramadol) Steroid injections | Medications available for OA? |
Joint replacement (esp. knees and | Surgery available for OA? |
PT for muscle strength, range of motionMedical unloader braces Assistive devices | Therapy available for OA? |
Weight reductionExercise | Lifestyle changes that would help with OA? |
CapsaicinDiclofenac patches Lidocaine patches | Patches /topical drugs available for OA? |
Chronic systemic, autoimmune, inflammatory disorder | What is Rheumatoid Arthritis, in a nutshell? |
Synovial tissue becomes inflamed, and proliferates, forming pannus. These pannus invade bone, cartilage, and ligaments | Primary disease process in RA? |
Symmetric synovitis (typically bilateral, and across the joint itself)Bony erosions at the joint margins There are also many extraarticular manifestations: (see other slides) | Signs of RA? |
35-45 years old1/3 after the age of 60 | Peak age of RA? |
1% of world popF:M 3:1 | Prevalence and sex disparities in RA? |
Functional limitation and 30% of patients lose of work within the first five years due to functional impairment (although this is getting better) | Progression of RA? |
Synovial tissue | What is the primary target of the autoimmune inflammatory process that happens in RA? |
EdemaAngiogenesis Hyperplasia of synovial lining and inflammatory infiltrates | Signs of early stage RA? |
Massive hyperplasia of type A synovial cellsSubintimal mononuclear cell infiltration Extensive infiltration by plasma cells, macrophages, lymphocytes Pannus formation | Signs of late stage RA? |
Subintimal mononuclear cell infiltration: plasma cells, macropahges, lymphocytes.Late stages of RA | Cell types seen in RA, and when along the course of disease? |
Normal on leftRA on right | ![]() |
Slide showing normal synoviumSynovial cells are basically a few cell layers deep | ![]() |
Synovitis in the setting of RAThickening of the layer, with lots and lots of cells (almost looks like granulation tissue). This is before the formation of pannus | ![]() |
Pannus, formed from the synovium, in the setting of late stage RA. Cartilage is starting to invade. | ![]() |
Soluble TNF receptorIL-10 IL-1 receptor antagonist | What cytokines are considered anti-inflammatory in the setting of RA? |
TNFalphaIL-1 These are produced in excess of IL-10 and other anti-inflammatory chemical seen in the setting of RA | What cytokines are considered inflammatory in the setting of RA? |
DIPs, thoracic and lumbar spineLarge joints involved later in the disease process | What joints are spared in early RA? |
Small joints in hands and feet:MCPs MTPs PIPs Usually joints are affected bilaterally | What joints are hit hardest in RA? |
MCP 90-95%Wrist 80-90% PIP 65-90% Knee 60-80% MTP 50-90% Shoulder 50-60% Ankle/subtalar 50-80% Cervical spine 40-50% Hip 40-50% Elbow 40-50% Temporomandibular 20-30% | Most commonly affected joints in RA? |
| Fusiform swelling seen in RA Soft-tissue swelling is an early finding in rheumatoid arthritis and usually appears as typical fusiform or spindle-shaped enlargement of the proximal interphalangeal joints. The second and third fingers of this patient are most involved. These proximal interphalangeal joints are tender and have a limited range of motion. If you push on this, it will be very boggy and squishy. Totally unlike OA | ![]() |
| A woman with long standing rheumatoid arthritis has soft tissue swelling and subluxation of the metacarpophalangeal joints. The right thumb shows hyperextension of the interphalangeal joint (a Z deformity). Both ring fingers have Boutonniere deformities with flexion of the proximal and hyperextension of the distal interphalangeal joints. | ![]() |
Soft tissue swelling over the ulnar styloid. | What is ulnar styloid prominence in the setting of RA? |
Feature of RA. Weakening of the central slip of the extensor tendon, and palmar displacement of the lateral bands | What is Boutonniere deformity? |
Feature of RA. Contraction of the flexons of the MCPs | What is a Swan Neck deformity? |
Hand deformities seen in RA.MCP swelling with lateral deviation. You can also see swelling along the ulnar prominence | ![]() |
Swan neck hand deformity seen in RAAlso Boutonniere deformity seen in the pink (slipping of tendon sheets seen underneath). | ![]() |
Arthritis Mutilans, seen in very severe RA. Medications can prevent this kind of disease, but we still see this presented. One feature of this is that the ulnar styloid has basically been eroded down and away. | ![]() |
Cock up or Hammer toe deformity, can be a feature of RA | ![]() |
Uniform narrowing of the joint capsule at the knees, this can be a feature of RA.No sclerosis No bone spurs | ![]() |
Rheumatoid nodulesVasculitis Fragility Pyoderma gangrenosum | Skin manifestations of RA? |
ScleritisEpiscleritis Iritis Keratoconjunctivitis Sicca Scleromalacia perforans | Eye manifestations of RA? |
Pleural effusionsInterstitial lung disease Bronchiolitis obliterans Rheum nodules Vasculities | Pulmonary manifestations of RA? |
PericarditisPericardial effusion Vasculitis Valve disease Conduction defects CAD | Cardiac involvement of RA? |
OsteoporosisOsteopenia | Other bone manifestations of RA? |
Skin (e.g. Rheumatoid nodules)Eye Lungs Heart Bone Neurologic Hematopoietic Kidney | Extra-articular RA manifestations typically affect what systems? |
Entrapment neuropathyCervical myelopathy Mononeuritis multiplex (vasculitis) Peripheral neuropathy (CTS, TTS) | Neuro manifestations of RA? |
AnemiaThrombocytosis Lymphadenopathy Felty's syndrome (triad of RA, splenomegaly, neutropenia) | Hematopoietic manifestations of RA? |
RASplenomegaly Neutropenia | What is the triad of Felty's syndrome? |
AmyloidosisVasculitis | Kidney manifestations of RA? |
Rheumatoid nodule, seen in the setting of RA. Extensor surface of elbows, you can see these on other joints and tendons.Rubbery, firm sort of nodule. | ![]() |
Scleromalacia perforansThis is basically thinning of the sclera, with the uvea trying to poke through | ![]() |
White males | Who usually gets a RA-associated lung manifestations? |
Vasculitis associated with RA | ![]() |
Sjogren's syndrome seen in the setting of RA.Dry eyes, dry mouth, parotid enlargement. (Sjogren syndrome is an autoimmune disorder in which the glands that produce tears and saliva are destroyed, causing dry mouth and dry eyes. However, the condition may affect many different parts of the body, including the kidneys and lungs.) | ![]() |
Biologic agents, new class of therapies of cytokine blockade. | What newish drug type has drastically changed outcomes and morbidity of RA? |
NSAIDsSteroids (oral or intraarticular) Disease Modifying Anti-rheumatic Drugs (DMARDS) Biologics (Enbrel, Humira) | Drug classes used for RA? |
Over the long term, potential for kidney, liver, and GI toxicity | Problems with using NSAIDs for RA |
Many, many side effects if using these long term | Problems with using steroids for RA? |
Liver, BM toxicity | Problems with using Disease Modifying Anti-rheumatic drugs for RA? |
Potential for reactivation of latent TB, infections | Problems with using biologic agents for RA? |
MTXSulfasalazine Gold sodium thiomalate Hydroxycholorquine sulfate Cyclosporine Leflunomide | Examples of DMARDs? |
Methotrexate (7.5-25 mg PO, SC, or IM once weekley).Used typically orally. Also used: Sulfasalazine Leflunomide Not really used: Cyclosporine | Gold standard go to DMARD for RA? What other ones are actually used? |
No liver or kidneysPossible retinal toxicity | Problems with using Hydroxychloroquine sulfate for RA |
Gold sodium thiomalate | DMARD with the most toxic effects? |
Hydroxychloroquine sulfate (but yes to possible retinal toxicity) | DMARD with the least toxic effects? |
Anti-TNFalpha (Infliximab)Anti-CD20 (Rituximab) Anti-IL1 (Anakinra) Costim mod that inhibits T-cell activation (Abatacept) Anti-IL6 (Tocilizumab) | Main biologic classes used for RA? |
Anti-TNFalpha.Given q6-8 weeks for RA | What is Infliximab? |
Anti-TNFalphaSQ qW | What is Etanercept? |
Anti-TNFalphaSQ qOW | What is Adalimumab? |
Anti-TNFalphaThis is pegylated, so we can give it SQ qMonth | What is Golimumab? |
Anti-TNFalpha2SQ qMonth | What is Certolizumab? |
Anti-CD20Infusion at Day 1/15 | What is Rituximab? |
Anti-IL1SQ qDay, so not very popular | What is Anakinra? |
Biologic drug: Costim modulator that inhibits T-cell activationInfusion/SQ at day 1, then SQ qWeek | What is Abatacept? |
Anti-IL6 biologicInfused q4 weeks | What is Tocilizumab? |
RA has erosions, osteopenias, etc. Also more likely to be symmetricOA has spur formation, osteophytic growth, sclerosis etc. Both have cysts and narrowing of the joint space. (RA may have osteophytes and sclerosis, but not as likely) | Bone involvements in RA vs OA? |
RA: 25-50OA: after age 40 | Age of onset: RA vs OA? |
RA: MCP, PIP, not TL spineOA: DIP, PIP, LS spine | Joint differences between RA and OA? |
OAYou see bone formation at the DIPs You also see that the MCPs are pretty well preserved. | ![]() OA or RA? |
OAA lot of sclerosis. not very uniform throughout the joint itself. | ![]() OA or RA? |
First Time Here?
Welcome to Quizlet, a fun, free place to study. Try these flashcards, find others to study, or make your own.


























